Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 1
1 January 1998
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265

Minireview

The role of DNA mismatch repair in drug resistance.
D Fink; S Aebi; S B Howell
View articletitled, The role of DNA mismatch repair in drug resistance.
Open the PDF for in another window

Advances in Brief

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
R M Elledge; S Green; D Ciocca; R Pugh; D C Allred; G M Clark; J Hill; P Ravdin; J O'Sullivan; S Martino; C K Osborne
View articletitled, HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
Open the PDF for in another window

Research Articles

Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
J Rubin Grandis; D J Tweardy; M F Melhem
View articletitled, Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Open the PDF for in another window
CD44 expression in the stromal matrix of colorectal cancer: association with prognosis.
K Furuta; M Zahurak; S N Goodman; S R Hamilton; J T August
View articletitled, CD44 expression in the stromal matrix of colorectal cancer: association with prognosis.
Open the PDF for in another window
Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.
Y Ogawa; K Hirakawa; B Nakata; T Fujihara; T Sawada; Y Kato; K Yoshikawa; M Sowa
View articletitled, Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.
Open the PDF for in another window
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
N Dawson; W D Figg; O W Brawley; R Bergan; M R Cooper; A Senderowicz; D Headlee; S M Steinberg; M Sutherland; N Patronas; E Sausville; W M Linehan; E Reed; O Sartor
View articletitled, Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
Open the PDF for in another window
Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
V I Avramis; S Wiersma; M D Krailo; L V Ramilo-Torno; A Sharpe; W Liu-Mares; R Kowck; G H Reaman; J K Sato
View articletitled, Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
Open the PDF for in another window
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.
G R Weiss; I Poggesi; M Rocchetti; D DeMaria; T Mooneyham; D Reilly; L V Vitek; F Whaley; E Patricia; D D Von Hoff; P O'Dwyer
View articletitled, A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.
Open the PDF for in another window
Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.
S C Srivastava; H L Atkins; G T Krishnamurthy; I Zanzi; E B Silberstein; G Meinken; L F Mausner; F Swailem; T D'Alessandro; C J Cabahug; Y Lau; T Park; S Madajewicz
View articletitled, Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.
Open the PDF for in another window
Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia.
R Riccardi; A Riccardi; A Lasorella; T Servidei; S Mastrangelo
View articletitled, Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia.
Open the PDF for in another window
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.
E Bajetta; M Del Vecchio; R Mortarini; R Nadeau; A Rakhit; L Rimassa; C Fowst; A Borri; A Anichini; G Parmiani
View articletitled, Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.
Open the PDF for in another window
Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
C Vallbo; A T Bergenheim; P Bergström; P O Gunnarsson; R Henriksson
View articletitled, Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
Open the PDF for in another window
Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
Y Fan; L Einhorn; S Saxman; B Katz; R Abonour; K Cornetta
View articletitled, Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
Open the PDF for in another window
Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
T J Kinsella; K A Kunugi; K A Vielhuber; D M Potter; M E Fitzsimmons; J M Collins
View articletitled, Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
Open the PDF for in another window
Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.
G Storm; M T ten Kate; P K Working; I A Bakker-Woudenberg
View articletitled, Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.
Open the PDF for in another window
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.
I I Budihardjo; D L Walker; P A Svingen; C A Buckwalter; S Desnoyers; S Eckdahl; G M Shah; G G Poirier; J M Reid; M M Ames; S H Kaufmann
View articletitled, 6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.
Open the PDF for in another window
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione.
X Chen; R L Schecter; O W Griffith; M A Hayward; L C Alpert; G Batist
View articletitled, Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione.
Open the PDF for in another window
Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.
X Gao; J L Au; R A Badalament; M G Wientjes
View articletitled, Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.
Open the PDF for in another window
Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
A A Gibson; F G Harwood; D M Tillman; J A Houghton
View articletitled, Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
Open the PDF for in another window
Modulation of cancer chemotherapy by green tea.
Y Sadzuka; T Sugiyama; S Hirota
View articletitled, Modulation of cancer chemotherapy by green tea.
Open the PDF for in another window
A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
D L Coleman; N Canak; G D Place; C Shih; R R Bowsher
View articletitled, A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
Open the PDF for in another window
In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates.
Y Messinger; Y Yanishevski; O Ek; T Zeren; B Waurzyniak; R Gunther; L Chelstrom; M Chandan-Langlie; E Schneider; D E Myers; W Evans; F M Uckun
View articletitled, In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates.
Open the PDF for in another window
Antitumor activity of actinonin in vitro and in vivo.
Y Xu; L T Lai; J L Gabrilove; D A Scheinberg
View articletitled, Antitumor activity of actinonin in vitro and in vivo.
Open the PDF for in another window
Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
S J Kim; E Shiba; T Kobayashi; E Yayoi; J Furukawa; Y Takatsuka; E Shin; H Koyama; H Inaji; S Takai
View articletitled, Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
Open the PDF for in another window
Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
V M Whitehead; M J Vuchich; L Cooley; S J Lauer; D H Mahoney; J J Shuster; C Payment; M L Bernstein; J J Akabutu; T Bowen; B A Kamen; M S Watson; A T Look; D J Pullen; B Camitta
View articletitled, Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Open the PDF for in another window
Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.
J P Peyrat; L Vanlemmens; J Fournier; G Huet; F Révillion; J Bonneterre
View articletitled, Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.
Open the PDF for in another window
Genetic changes and telomerase activity in human renal cell carcinoma.
V Rohde; H P Sattler; B Oehlenschläger; S Forster; T Zwergel; G Seitz; B Wullich
View articletitled, Genetic changes and telomerase activity in human renal cell carcinoma.
Open the PDF for in another window
TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
A L Børresen-Dale; R A Lothe; G I Meling; P Hainaut; T O Rognum; E Skovlund
View articletitled, TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
Open the PDF for in another window
Genetic abnormalities in parathyroid nodules of uremic patients.
J Chudek; E Ritz; G Kovacs
View articletitled, Genetic abnormalities in parathyroid nodules of uremic patients.
Open the PDF for in another window
Gene amplification as a prognostic factor in primary brain tumors.
J J Olson; D Barnett; J Yang; R Assietti; G Cotsonis; C D James
View articletitled, Gene amplification as a prognostic factor in primary brain tumors.
Open the PDF for in another window
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
I Bongarzone; P Vigneri; L Mariani; P Collini; S Pilotti; M A Pierotti
View articletitled, RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Open the PDF for in another window
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
K Yashima; S Milchgrub; L S Gollahon; A Maitra; M H Saboorian; J W Shay; A F Gazdar
View articletitled, Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Open the PDF for in another window
Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
H Aida; K Takakuwa; H Nagata; I Tsuneki; M Takano; S Tsuji; T Takahashi; T Sonoda; M Hatae; K Takahashi; K Hasegawa; H Mizunuma; N Toyoda; H Kamata; Y Torii; N Saito; K Tanaka; M Yakushiji; T Araki; K Tanaka
View articletitled, Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
Open the PDF for in another window
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
G Fontanini; M De Laurentiis; S Vignati; S Chinè; M Lucchi; V Silvestri; A Mussi; S De Placido; G Tortora; A R Bianco; W Gullick; C A Angeletti; G Bevilacqua; F Ciardiello
View articletitled, Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Open the PDF for in another window
Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
R D Meng; H Shih; N S Prabhu; D L George; W S el-Deiry
View articletitled, Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
Open the PDF for in another window

Letter to the Editor

Correspondence Re: C. Caserini et al., Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Clin. Cancer Res., 3: 955-961, 1997.
V R Bulusu
View articletitled, Correspondence Re: C. Caserini et al., Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Clin. Cancer Res., 3: 955-961, 1997.
Open the PDF for in another window

Advertisement

Breaking
$500,000 Purse Announced for TBXT Drugs
B7-H4 Inhibitor Effective for Some Triple-Negative Breast Cancers
CAR-Related T-Cell Malignancies Rare, Another Study Finds
View more recent articles
Latest News
Greater Certainty of Survival Valued Over Speedier Drug Access
Keto Diet Key to Fueling CARs?
ADC for Lymphoma Elicits Near-Perfect Response Rate
View more recent articles
Research Watch
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept